hrcak mascot   Srce   HID

Pregledni rad

ALGORITHMS FOR PERIPROCEDURAL MANAGEMENT AND MANAGEMENT OF BLEEDING IN PATIENTS TREATED WITH NON-VITAMIN K ORAL ANTICOAGULANTS

Ivan Gornik
Ingrid Prkačin
Višnja Nesek Adam
Vlatko Grabovac
Vanja Giljača
Aljoša Šikić

Puni tekst: hrvatski, pdf (901 KB) str. 0-0 preuzimanja: 616* citiraj
APA 6th Edition
Gornik, I., Prkačin, I., Nesek Adam, V., Grabovac, V., Giljača, V. i Šikić, A. (2017). POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA. Liječnički vjesnik, 139 (3-4), 0-0. Preuzeto s https://hrcak.srce.hr/184329
MLA 8th Edition
Gornik, Ivan, et al. "POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA." Liječnički vjesnik, vol. 139, br. 3-4, 2017, str. 0-0. https://hrcak.srce.hr/184329. Citirano 23.10.2019.
Chicago 17th Edition
Gornik, Ivan, Ingrid Prkačin, Višnja Nesek Adam, Vlatko Grabovac, Vanja Giljača i Aljoša Šikić. "POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA." Liječnički vjesnik 139, br. 3-4 (2017): 0-0. https://hrcak.srce.hr/184329
Harvard
Gornik, I., et al. (2017). 'POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA', Liječnički vjesnik, 139(3-4), str. 0-0. Preuzeto s: https://hrcak.srce.hr/184329 (Datum pristupa: 23.10.2019.)
Vancouver
Gornik I, Prkačin I, Nesek Adam V, Grabovac V, Giljača V, Šikić A. POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA. Liječnički vjesnik [Internet]. 2017 [pristupljeno 23.10.2019.];139(3-4):0-0. Dostupno na: https://hrcak.srce.hr/184329
IEEE
I. Gornik, I. Prkačin, V. Nesek Adam, V. Grabovac, V. Giljača i A. Šikić, "POSTUPNICI ZA PERIPROCEDURALNO ZBRINJAVANJE I ZBRINJAVANJE KRVARENJA U BOLESNIKA LIJEČENIH NOVIM ORALNIM ANTIKOAGULANTNIM LIJEKOVIMA", Liječnički vjesnik, vol.139, br. 3-4, str. 0-0, 2017. [Online]. Dostupno na: https://hrcak.srce.hr/184329. [Citirano: 23.10.2019.]

Sažetak
The goal of therapy with vitamin K antagonists (warfarin), and new direct oral anticoagulant drugs (NOAC or DOAC) is the prevention of stroke and embolic events in patients with non-valvular atrial fibrillation and treatment and prevention of venous thromboembolism. In all cases it is necessary to determine renal function with creatinine clearance because it determines the choice and dosage of NOAC’s. It is extremely important to pay attention to older patients with a number of associated conditions and drug interactions, with a high incidence of neurological symptoms and worse outcomes. Oral anticoagulation can represent a challenge, especially in cases of drug overdose or emergencies such as bleeding and need for urgent surgery. The need for the guidelines has emerged during the last years because of new classes of oral anticoagulants being prescribed more frequently. The expert working group of emergency specialists was formed and gathered on Consensus Conference in October 2015 in Zagreb, to design guidelines for the patients with NOAC therapy and provides details of preoperative management and managements in emergency conditions.

Ključne riječi
Anticoagulants – adverse effects, therapeutic use; Administration, oral; Vitamin K – antagonists and inhibitors; Warfarin – adverse effects, therapeutic use; Atrial fi brillation – complications, drug therapy; Stroke – etiology, prevention and control; Venous thromboembolism – drug therapy, prevention and control; Hemorrhage – etiology, prevention; Glomerular fi ltration rate; Creatinine – blood; Emergencies; Preoperative care; Algorithms

Hrčak ID: 184329

URI
https://hrcak.srce.hr/184329

[hrvatski]

Posjeta: 789 *